The price revision, effective April 3, 2026, will bring the innovator molecule within the reach of a significantly larger patient base across the country
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
AbbVie will offer reduced prices for its medicines in Medicaid and commit $100 billion over the next decade to US research, development and capital investments, including domestic manufacturing
Patients can now get the starting 2.5 mg dose for $299 per month
The deal, backed by Gavi and executed by UNICEF, could generate up to US$90 million in savings—enough to provide more than 30 million additional doses
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The offering is expected to close on November 10, 2025, subject to customary closing conditions
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Subscribe To Our Newsletter & Stay Updated
